GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
7L8A | 7L8A | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.33104 (Wk26 time point) | |
7L89 | 7L89 | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-4 from animal Rh.32034 (Wk26 time point) | |
7L88 | 7L88 | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.32034 (Wk26 time point) | |
7L87 | 7L87 | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-2 from animal Rh.32034 (Wk26 time point) | |
7L86 | 7L86 | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-1 from animal Rh.32034 (Wk26 time point) | |
7L7U | 7L7U | BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component B) | |
7L7T | 7L7T | BG505 SOSIP reconstructed from a designed nanoparticle, BG505 SOSIP-T33-31 (Component A) | |
7L7R | 7L7R | CCHFV Gc prefusion monomer bound to ADI-36121 and ADI-37801 Fabs | |
7L7R | Q8JSZ3 | CCHFV Gc prefusion monomer bound to ADI-36121 and ADI-37801 Fabs | |
7L7E | 7L7E | Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061 | |
7L7E | P0DTC2 | Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibodies AZD8895 and AZD1061 | |
7L7D | P0DTC2 | Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibody AZD8895 | |
7L7D | 7L7D | Crystal structure of SARS-CoV-2 spike RBD in complex with human monoclonal antibody AZD8895 | |
7L74 | Q564N5 | Crystal structure of Beta-hexosyl transferase from Hamamotoa (Sporobolomyces) singularis bound to TRIS | |
7L6T | P0DTD1 | Crystal Structure of SARS-CoV-2 Nsp16/10 Heterodimer in Complex with (m7GpppA2m)pUpUpApApA (Cap-1), S-Adenosyl-L-homocysteine (SAH) and two Magnesium (Mg) ions. | |
7L6R | P0DTD1 | Crystal Structure of SARS-CoV-2 Nsp16/10 Heterodimer in Complex with (m7GpppA2m)pUpUpApApA (Cap-1), S-Adenosyl-L-homocysteine (SAH) and Manganese (Mn). | |
7L6O | A0A1W6IPB2 | Cryo-EM structure of HIV-1 Env CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 | |
7L6O | 7L6O | Cryo-EM structure of HIV-1 Env CH848.3.D0949.10.17chim.6R.DS.SOSIP.664 | |
7L67 | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Fuc-(alpha1-3)-GlcNAc | |
7L66 | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Methyl-GlcNAc | |
7L65 | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Methyl-GlcNAc | |
7L64 | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with Lewis-a | |
7L63 | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose | |
7L62 | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose | |
7L61 | P22897 | C-type carbohydrate-recognition domain 4 of the mannose receptor complexed with L-fucose-(alpha 1-2)-D-galactose-(beta1-4)-D-glucose | |
7L5K | A0A768MZ64 | Crystal structure of the DiB-RM protein | |
7L58 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4 | |
7L58 | 7L58 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab H4 | |
7L57 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15 | |
7L57 | 7L57 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-15 | |
7L56 | P0DTC2 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43 | |
7L56 | 7L56 | Cryo-EM structure of the SARS-CoV-2 spike glycoprotein bound to Fab 2-43 | |
7L4Z | P0DTC2 | Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide | |
7L4Z | 7L4Z | Structure of SARS-CoV-2 spike RBD in complex with cyclic peptide | |
7L3N | P0DTC2 | SARS-CoV 2 Spike Protein bound to LY-CoV555 | |
7L3N | 7L3N | SARS-CoV 2 Spike Protein bound to LY-CoV555 | |
7L31 | P23416 | Cyro-EM structure of human Glycine Receptor alpha2-beta heteromer, strychnine bound state, 3.8 Angstrom | |
7L31 | P42212 | Cyro-EM structure of human Glycine Receptor alpha2-beta heteromer, strychnine bound state, 3.8 Angstrom | |
7L31 | P48167 | Cyro-EM structure of human Glycine Receptor alpha2-beta heteromer, strychnine bound state, 3.8 Angstrom | |
7L2F | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
7L2F | 7L2F | Cryo-EM structure of NTD-directed neutralizing antibody 5-24 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
7L2E | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
7L2E | 7L2E | Cryo-EM structure of NTD-directed neutralizing antibody 4-18 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
7L2D | P0DTC2 | Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
7L2D | 7L2D | Cryo-EM structure of NTD-directed neutralizing antibody 1-87 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
7L2C | P0DTC2 | Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-terminal domain (NTD) | |
7L2C | 7L2C | Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-terminal domain (NTD) | |
7L21 | P14618 | Pyruvate Kinase M2 mutant-N70D | |
7L1Y | 7L1Y | Unlocking the structural features for the exo-xylobiosidase activity of an unusual GH11 member identified in a compost-derived consortium-xylobiose complex | |
7L17 | P30878 | Crystal structure of sugar-bound melibiose permease MelB |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024